Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
03/2014
03/05/2014CN102580115B Tuberculosis mucosa gene vaccine assembled by using chitosan oligosaccharide delivery system and preparation and application of tuberculosis mucosa gene vaccine
03/05/2014CN102242080B Method for treating or diagnosing heart failure or tendency of heart failure or improving functions of myocardial cells by miR-24 (MicroRNA-24)
03/05/2014CN101745151B Preparation method of gene-activated poly-lactic acid material for treating liver diseases
03/04/2014US8664360 BSL3 polypeptides
03/04/2014US8664194 Method for producing a protein of interest in a primate
03/04/2014US8664193 Compositions and methods for inhibiting expression of factor VII gene
03/04/2014US8664191 Use of two microRNA moleculars in lung cancer prognosis and medicine preparation
03/04/2014US8664190 Methods for treating hypercholesterolemia
03/04/2014US8664189 RNA interference in skin indications
03/04/2014US8663657 Nucleic acid constructs
03/04/2014US8663652 Regeneration of endogenous myocardial tissue
03/04/2014US8663637 Methods and compositions for modulation of Olfml3 mediated angiogenesis
03/04/2014CA2444164C Pufa polyketide synthase systems and uses thereof
02/2014
02/27/2014WO2014031982A2 Methods and compositions for treating pain
02/27/2014WO2014030602A1 Agent for treating cancer
02/27/2014WO2014030147A2 Synthetic proteins based on dendrimers
02/27/2014WO2014029143A1 Plant extract-mediated drug transdermal introducing system and transdermal method thereof
02/27/2014WO2014007620A3 Oligonucleotide for the treatment of muscular dystrophy patients
02/27/2014WO2012122219A3 Predictive marker of dnmt1 inhibitor therapeutic efficacy and methods of using the marker
02/27/2014US20140057974 Methods for therapy of neurodegenerative disease of the brain
02/27/2014US20140057969 Oncovector Nucleic Acid Molecules and Methods of Use
02/27/2014US20140057963 Oligomeric compounds and compositions for use in modulation of small non-coding rnas
02/27/2014US20140057337 System and method for electroporating a sample
02/27/2014US20140056922 Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
02/27/2014US20140056872 Antagonists of neuropilin receptor function and use thereof
02/27/2014US20140056815 Methods to regulate polarization and enhance function of cells
02/26/2014EP2700720A2 Compositions and methods for optimizing cleavage of RNA by RNASE H
02/26/2014EP2699697A1 METHODS OF USING miRNA FROM BODILY FLUIDS FOR EARLY DETECTION AND MONITORING OF MILD COGNITIVE IMPAIRMENT (MCI) AND ALZHEIMER'S DISEASE (AD)
02/26/2014EP2699680A2 Raav-based compositions and methods for treating alpha-1 anti-trypsin deficiencies
02/26/2014EP2699673A2 Recombinant virus products and methods for inhibition of expression of myotilin
02/26/2014EP2699270A2 Adeno-associated virus virions with variant capsid and methods of use thereof
02/26/2014EP2699258A2 Aav mediated ctla-4 gene transfer to treat sjogren's syndrome
02/26/2014CN103608455A Promoters, expression cassettes, vectors, kits and methods for the treatment of achromatopsia and other diseases
02/26/2014CN103608042A A method for manufacturing pegylated oligonucleotides
02/26/2014CN103608028A Human myeloid derived suppressor cell cancer markers
02/26/2014CN103602724A Methods for determining hepatocellular carcinoma subtype and detecting hepatic cancer stem cells
02/26/2014CN103602706A MUC1 (Mucins 1) and GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) dual-gene co-expression recombinant vector and preparation method and application thereof
02/26/2014CN103602695A GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) and MART-1 (Melanoma Antigen Recognized By T-Cells 1) dual-gene co-expression recombinant vector and preparation method and application thereof
02/26/2014CN103602689A Development of dengue virus vaccine components
02/26/2014CN103602625A Escherichia coli containing recombinant adenovirus plasmids and applications of recombinant adenovirus plasmids
02/26/2014CN103599549A SiRNA (Small interfering Ribonucleic Acid)/anti-cancer drug combined transferring composite supporter and preparation method and application thereof
02/26/2014CN102614528B Polyconjugates for in vivo delivery of polynucleotides
02/26/2014CN102585151B Polyurethane segmented copolymer containing disulfide bonds and tertiary amine groups as well as preparation method of polyurethane segmented copolymer
02/26/2014CN102370977B Novel vaccine adjuvant and application
02/26/2014CN102344489B Modified sodium iodine symporter protein and application thereof
02/26/2014CN102329809B Reverse genetic operating system of canine distemper virus (CDV)/R-20/8 vaccine strain and application thereof
02/26/2014CN102093477B Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same
02/26/2014CN101837125B Method of regulating phosphorylation of PTH protein and antiviral agents comprising SR protein activity regulator as the active ingredient
02/25/2014US8658785 siRNA targeting tie-2
02/25/2014US8658783 Antisense modulation of PTP1B expression
02/25/2014US8658614 Aptamer-containing compositions and methods for targeting E-selectin
02/25/2014US8658611 Apoptosis-inducing agent for prostate cancer cells
02/25/2014US8658610 Replication-competent anti-cancer vectors
02/25/2014US8658609 Modulation of bio-electrical rhythms via a novel engineering approach
02/25/2014US8658607 Immunostimulatory G, U-containing oligoribonucleotides
02/25/2014US8658356 Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
02/25/2014US8658204 Transpulmonary liposome for controlling drug arrival
02/25/2014CA2788707C Compositions and methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells
02/25/2014CA2575926C Canine specific growth hormone releasing hormone
02/25/2014CA2538252C 4'-thionucleosides and oligomeric compounds
02/25/2014CA2376665C Novel tet repressor-based transcriptional regulatory proteins
02/20/2014WO2014028762A1 Compositions and methods for treating peripheral arterial disease
02/20/2014WO2014028493A2 Exosomes and micro-ribonucleic acids for tissue regeneration
02/20/2014WO2014027668A1 Reelin decomposition using adamts-3
02/20/2014WO2014027608A1 Brown adipocyte differentiation-inducing agent
02/20/2014WO2013151665A3 Modified polynucleotides for the production of proteins associated with human disease
02/20/2014US20140051166 Method and medicament for inhibiting the expression of a given gene
02/20/2014US20140050701 CAPSID-MODIFIED rAAV VECTOR COMPOSITIONS HAVING IMPROVED TRANSDUCTION EFFICIENCIES, AND METHODS OF USE
02/19/2014EP2698164A1 Dna vaccine
02/19/2014EP2696886A2 C1q/tnf-related protein 12 and compositions and methods of using same
02/19/2014CN1350592B Nucleic acid probe-based diagnostic assays for prokaryotic and eukaryotic organisms
02/19/2014CN103589754A Herpes simplex virus type 1 carrier system, and preparation method and application thereof
02/19/2014CN103589753A shRNA slow virus expression vector of specific inhibition human SIRT1 gene expression and establishing method and application thereof
02/19/2014CN103589738A Modification of HIV-1 (Human immunodeficiency virus type one) Chinese epidemic strain CRF01_AE env gene
02/19/2014CN103589727A siRNA capable of suppressing expression of gene TLR2 of human immune cell and application of siRNA
02/19/2014CN103589721A Extraction, preparation and application of plant micro ribonucleic acid
02/19/2014CN103589692A A method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
02/19/2014CN103588874A Human anti-HBV surface antigen genetic engineering antibody, and preparation method and application thereof
02/19/2014CN103585643A Newcastle disease virus vectored avian vaccines
02/19/2014CN103585631A Method for preventing and treating tumors by using microRNA sponge technology
02/19/2014CN103585629A New target for preventing and treating insulin resistance and its related diseases
02/19/2014CN103585621A Treatment of a alpha-galactosidase a deficiency
02/19/2014CN102813941B Application of growth factor gene drug in preventing and treating stress-related gastrointestinal injury
02/19/2014CN102807609B Polypeptide for preventing and/or treating pain and application of polypeptide
02/19/2014CN102604946B Small interfering ribonucleic acid (siRNA) for inhibiting tumor metastasis and application thereof
02/19/2014CN102453713B HULC siRNA and use of HULC siRNA in preparation of drugs for treatment of liver cancer
02/19/2014CN102453712B PI4KB siRNA and application thereof in preparation of medicament for inhibiting SARS-CoV infection
02/18/2014US8653047 Modulation of angiopoietin-like 3 expression
02/18/2014US8653045 Induction of thyroid iodide-handling gene expression in human cancers
02/18/2014US8652807 Lentiviral vectors for the preparation of immunotherapeutical compositions
02/18/2014US8652504 Solid polymer delivery compositions and methods for use thereof
02/18/2014US8652462 Immune regulation
02/18/2014US8652460 Gene delivery system and method of use
02/18/2014US8652459 Splitting GP41
02/18/2014CA2674838C Anti-ige vaccines
02/18/2014CA2538840C Dna vaccine compositions and methods of use
02/18/2014CA2503442C Methods of diagnosing ischemia using eif-5a
02/18/2014CA2472203C The use of il6r/il6 chimera in nerve cell regeneration
02/18/2014CA2454756C Methods and compounds for the targeting of protein to exosomes
02/18/2014CA2451741C Peyers's patch and/or m-celle targeting ligands
1 ... 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 ... 870